Frankfurt - Delayed Quote EUR

4SC AG (VSC.F)

8.86 -0.02 (-0.23%)
At close: April 26 at 3:24 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
304.00
304.00
436.00
14,109.00
2,252.00
Cost of Revenue
95.00
95.00
155.00
383.00
519.00
Gross Profit
209.00
209.00
281.00
13,726.00
1,733.00
Operating Expense
8,635.00
8,635.00
13,960.00
21,969.00
21,284.00
Operating Income
-8,426.00
-8,426.00
-13,679.00
-8,243.00
-19,551.00
Net Non Operating Interest Income Expense
159.00
159.00
--
3.00
66.00
Pretax Income
-8,222.00
-8,222.00
-14,361.00
-9,628.00
-18,988.00
Tax Provision
15.00
15.00
--
--
--
Net Income Common Stockholders
-8,237.00
-8,237.00
-14,361.00
-9,628.00
-18,988.00
Diluted NI Available to Com Stockholders
-8,237.00
-8,237.00
-14,361.00
-9,628.00
-18,988.00
Basic EPS
-0.81
--
-1.42
-0.95
-2.05
Diluted EPS
-0.81
--
-1.42
-0.95
-2.05
Basic Average Shares
10,169.14
--
10,113.38
10,134.74
9,272.00
Diluted Average Shares
10,169.14
--
10,113.38
10,134.74
9,272.00
Total Operating Income as Reported
--
--
--
-8,650.00
-19,449.00
Rent Expense Supplemental
--
--
--
37.00
38.00
Total Expenses
8,730.00
8,730.00
14,115.00
22,352.00
21,803.00
Net Income from Continuing & Discontinued Operation
-8,237.00
-8,237.00
-14,361.00
-9,628.00
-18,988.00
Normalized Income
-8,275.25
-8,275.25
-13,754.00
-8,231.00
-19,421.32
Interest Income
262.00
262.00
--
4.00
120.00
Interest Expense
103.00
103.00
--
1.00
35.00
Net Interest Income
159.00
159.00
--
3.00
66.00
EBIT
-8,119.00
-8,119.00
-14,361.00
-9,627.00
-18,953.00
EBITDA
-7,588.00
-7,588.00
-12,593.00
-8,776.00
-17,823.00
Reconciled Cost of Revenue
95.00
95.00
155.00
383.00
519.00
Reconciled Depreciation
531.00
531.00
1,768.00
851.00
1,130.00
Net Income from Continuing Operation Net Minority Interest
-8,237.00
-8,237.00
-14,361.00
-9,628.00
-18,988.00
Total Unusual Items Excluding Goodwill
45.00
45.00
-607.00
-1,397.00
591.00
Total Unusual Items
45.00
45.00
-607.00
-1,397.00
591.00
Normalized EBITDA
-7,633.00
-7,633.00
-11,986.00
-7,379.00
-18,414.00
Tax Rate for Calcs
0.00
0.00
--
--
0.00
Tax Effect of Unusual Items
6.75
6.75
--
--
157.68
12/31/2020 - 12/15/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDG1.F Medigene AG
1.5250
+1.67%
 
HPHA.F Heidelberg Pharma AG
2.9100
-1.02%
 
05Y.F Vivoryon Therapeutics N.V.
0.7840
-6.33%
 
MDG1.DE Medigene AG
1.5050
-5.64%
 
CLABF Core One Labs Inc.
0.1435
-5.20%
 
SCNI Scinai Immunotherapeutics Ltd.
0.4578
+1.73%
 
BSLN.SW Basilea Pharmaceutica AG
40.30
+0.12%
 
CTNM Contineum Therapeutics, Inc.
15.72
-1.69%
 
FENC Fennec Pharmaceuticals Inc.
9.21
+0.55%
 
GYRE Gyre Therapeutics, Inc.
17.11
+4.78%